• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

多发性骨髓瘤自体外周血干细胞移植四年后发生霍奇金淋巴瘤

[Development of Hodgkin's disease four years after autologous peripheral blood stem cell transplantation for multiple myeloma].

作者信息

Fujii H, Iwai T, Ueda Y, Nakagawa H

机构信息

Department of Hematology, Kyoto First Red Cross Hospital.

出版信息

Rinsho Ketsueki. 2000 Dec;41(12):1267-72.

PMID:11201152
Abstract

We report a case of Hodgkin's disease that developed 4 years after autologous peripheral blood stem cell transplantation (PBSCT). The patient, a 67-year-old Japanese male, underwent PBSCT for multiple myeloma (IgA-lambda type) under a conditioning regimen of carboplatin, etoposide and cyclophosphamide in June 1994 and obtained partial remission. In January 1995, he underwent a second PBSCT under a conditioning regimen of high-dose melphalan and obtained complete remission. In December 1998, he noticed swelling of the left cervical lymph nodes, and Hodgkin's disease of the mixed cellularity subtype was diagnosed from a lymph node biopsy sample. Immunohistochemistry studies showed that the Hodgkin's and Reed-Sternberg cells were CD30-positive. In situ hybridization using EBER probes showed that these cells expressed EBER RNA transcripts, indicating that the tumor was associated with Epstein-Barr virus. One noteworthy feature was the absence of both M-component in the serum and urine, as revealed by immunoelectrofixation, and plasmacytosis in the bone marrow, which would have indicated relapse of the multiple myeloma. After chemotherapy with MOPP and ABVD, the Hodgkin's disease was eradicated and the patient obtained complete remission in May 1999.

摘要

我们报告一例霍奇金淋巴瘤,其在自体外周血干细胞移植(PBSCT)4年后发生。该患者为一名67岁的日本男性,于1994年6月在卡铂、依托泊苷和环磷酰胺预处理方案下接受了多发性骨髓瘤(IgA-λ型)的PBSCT,并获得部分缓解。1995年1月,他在大剂量美法仑预处理方案下接受了第二次PBSCT并获得完全缓解。1998年12月,他注意到左颈部淋巴结肿大,经淋巴结活检样本诊断为混合细胞型霍奇金淋巴瘤。免疫组织化学研究显示霍奇金和里德-斯腾伯格细胞CD30阳性。使用EBER探针的原位杂交显示这些细胞表达EBER RNA转录本,表明肿瘤与爱泼斯坦-巴尔病毒有关。一个值得注意的特征是,免疫电固定显示血清和尿液中均无M成分,骨髓中也无浆细胞增多,而这原本可能提示多发性骨髓瘤复发。经MOPP和ABVD化疗后,霍奇金淋巴瘤被根除,患者于1999年5月获得完全缓解。

相似文献

1
[Development of Hodgkin's disease four years after autologous peripheral blood stem cell transplantation for multiple myeloma].多发性骨髓瘤自体外周血干细胞移植四年后发生霍奇金淋巴瘤
Rinsho Ketsueki. 2000 Dec;41(12):1267-72.
2
[Complete remission of relapsed mixed cellularity Hodgkin's disease treated with rituximab].利妥昔单抗治疗复发的混合细胞型霍奇金病完全缓解
Dtsch Med Wochenschr. 2007 Aug;132(33):1688-91. doi: 10.1055/s-2007-984950.
3
Autotransplants for Hodgkin's disease in first relapse or second remission: a report from the autologous blood and marrow transplant registry (ABMTR).首次复发或第二次缓解期霍奇金病的自体移植:来自自体血液和骨髓移植登记处(ABMTR)的报告
Bone Marrow Transplant. 2001 Feb;27(4):387-96. doi: 10.1038/sj.bmt.1702796.
4
Modified conditioning regimen busulfan-cyclophosphamide followed by allogeneic stem cell transplantation in patients with multiple myeloma.改良预处理方案白消安-环磷酰胺序贯异基因干细胞移植治疗多发性骨髓瘤患者
Chin Med J (Engl). 2007 Mar 20;120(6):463-8.
5
Treatment of relapsed aggressive lymphomas: regimens with and without high-dose therapy and stem cell rescue.复发侵袭性淋巴瘤的治疗:含与不含高剂量治疗及干细胞救援的方案
Cancer Chemother Pharmacol. 2002 May;49 Suppl 1:S13-20. doi: 10.1007/s00280-002-0447-1. Epub 2002 Apr 12.
6
Systemic aspergillosis in a patient with non-Hodgkin's lymphoma developing acute graft-versus-host disease after autologous peripheral blood stem cell transplantation.一名非霍奇金淋巴瘤患者在自体外周血干细胞移植后发生急性移植物抗宿主病并出现系统性曲霉病。
Haematologica. 2002 Jul;87(7):ECR22.
7
Crescentic glomerulonephritis developing 3 months after autologous peripheral blood stem cell transplantation for non-Hodgkin's lymphoma.非霍奇金淋巴瘤自体外周血干细胞移植3个月后发生的新月体性肾小球肾炎。
Bone Marrow Transplant. 1998 Oct;22(7):725-7. doi: 10.1038/sj.bmt.1701410.
8
Peripheral blood progenitor cell collection without close monitoring of peripheral blood CD34+ cells: A feasible strategy for multiple myeloma or pre-treated Non-Hodgkin's Lymphoma patients mobilized with low-dose cyclophosphamide plus G-CSF.在不密切监测外周血CD34+细胞的情况下进行外周血祖细胞采集:一种适用于接受低剂量环磷酰胺加粒细胞集落刺激因子动员的多发性骨髓瘤或预处理非霍奇金淋巴瘤患者的可行策略。
Transfus Apher Sci. 2009 Apr;40(2):91-5. doi: 10.1016/j.transci.2009.01.015. Epub 2009 Feb 23.
9
High dose chemotherapy followed by autologous haemopoietic stem cell transplant in multiple myeloma.大剂量化疗后自体造血干细胞移植治疗多发性骨髓瘤
Natl Med J India. 2003 Jan-Feb;16(1):16-21.
10
Long-term results of autologous stem cell transplantation for Hodgkin's disease (HD) and low-/intermediate-grade B non-Hodgkin's lymphoma (NHL): a report from the Austrian Stem Cell Transplantation Registry (ASCTR).霍奇金淋巴瘤(HD)及低/中级别B细胞非霍奇金淋巴瘤(NHL)自体干细胞移植的长期结果:来自奥地利干细胞移植登记处(ASCTR)的报告
Ann Hematol. 2005 Jul;84(7):462-73. doi: 10.1007/s00277-004-1003-3. Epub 2005 Feb 23.

引用本文的文献

1
Fibroblast growth factor-2 (FGF2) and syndecan-1 (SDC1) are potential biomarkers for putative circulating CD15+/CD30+ cells in poor outcome Hodgkin lymphoma patients.成纤维细胞生长因子-2(FGF2)和多功能蛋白聚糖-1(SDC1)是预后不良的霍奇金淋巴瘤患者中假定循环CD15+/CD30+细胞的潜在生物标志物。
J Hematol Oncol. 2013 Aug 29;6:62. doi: 10.1186/1756-8722-6-62.